Innovative R&D and Dealmaking Opportunities
Insights and analysis to inform licensing, partnering and acquisition opportunities
Decision Resources’ Innovative R&D and Dealmaking Opportunities series is an essential tool for pharmaceutical business development and strategic planning teams. Each therapeutic-area focused report highlights opportunities to access, license or acquire novel drug candidates and technologies. Through analysis of innovative areas of research and early-stage activities of smaller biotech companies, business development teams can understand where key opportunities lie. Each report features a clinical development pipeline (Phase I-III) of novel drugs, a pipeline analysis and an overview of development programs by drug target or mechanism of action. Reports identify and highlight innovator companies that offer discovery, preclinical and clinical partnering opportunities. In addition, an analysis of recent corporate deals highlights current partnering and dealmaking strategies. Reports also include detailed information about the therapeutic area market landscape. Delivered in a PowerPoint deck, key findings can easily be incorporated into users’ own presentations and reports.
Therapeutic-area focused reports include:
- Immune/Inflammatory Biologics
- Viral Diseases
- Metabolic Diseases
- Oncology: Targeted Biologics
- Oncology: Targeted Small-Molecule Therapies
- Infectious Disease Vaccines
- Metabolic Diseases
Key Benefits:
- Identify emerging opportunities for licensing, partnering and acquisition
- Insight into R&D pipelines, including new molecular entities and novel biologics in clinical development
Key Users:
- Business Development
- Strategic Planning/ New Product Planning
- Competitive Intelligence